Skip to content

Hereditary Thyroid Cancer Multi-Analyte Panel, Blood

Published: August 9, 2026Updated: August 17, 2026

A blood-based panel that checks multiple genetic markers for inherited susceptibility to thyroid cancer.

Quick summary

["This test helps assess inherited thyroid cancer risk but does not diagnose thyroid cancer."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 17, 2026Editorial policy

Key facts at a glance

LOINC
106780-0
Short code
Heredit thyr cancer multi analy Bld/T
Synonyms
Heredit thyr cancer multi analy Bld/T
Category
thyroid
Sample
whole-blood
Container
Lavender-top (EDTA)
Units
N/A
Critical range
0.5 N/A – —
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
molgen
CPT
86038
Specimen volume
3 mL
Stability
Room temperature: 4h, Refrigerated: 24h
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

What is this test?

This is a blood-based genetic panel that examines multiple genes or genetic variants associated with inherited thyroid cancer risk. It is primarily used to evaluate hereditary susceptibility rather than detect a tumor that is already present.

Why might I need this test?

Your clinician may recommend it if you have thyroid cancer at a young age, multiple thyroid or related tumors, a strong family history, or another feature suggesting an inherited condition. A genetic counselor can explain whether this panel is appropriate for you.

How is the test performed?

A blood sample is collected, and the laboratory analyzes genetic material for selected cancer-related genes and variants. The exact genes tested depend on the laboratory and the ordered panel.

How do I prepare for the test?

Fasting is usually not required for a blood-based genetic test, but follow your clinician's instructions. Having a family history of thyroid or other endocrine tumors available may help with counseling and interpretation.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

A positive result may indicate an inherited gene change associated with thyroid cancer and other tumors, but it does not mean that cancer is currently present. A variant of uncertain significance may not establish increased risk and may require additional testing or updated interpretation. A negative result does not exclude all genetic causes of thyroid cancer or eliminate risk from family history without a known gene change.

Short name

Hereditary thyroid cancer panel

Frequently asked questions

Does this test diagnose thyroid cancer?
No. It evaluates inherited genetic susceptibility; diagnosing thyroid cancer usually requires a clinical examination and appropriate imaging or tissue testing.
Will the results change if I have no family history of thyroid cancer?
Yes. Personal features, such as very young age at diagnosis or certain tumor findings, may justify testing even without a clear family history. Your clinician can help decide whether the panel is appropriate.
What happens if a genetic variant is found?
A genetic counselor may explain the result and discuss whether enhanced screening or evaluation for other associated tumors is appropriate. The recommended follow-up depends on the specific variant and your personal and family history.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy